Search in:

mAbs Volume 14, 2022 - Issue 1

Submit an article Journal homepage

Open access

5,425

Views

CrossRef citations to date

Altmetric

Review

Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

Jingjing Zhanga Department of Pathogens and Infectious Disease Prevention and Control, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107ChinaView further author information

Han Zhangb Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, China, 650118Correspondence[email protected]

https://orcid.org/0000-0002-2684-512X View further author information

Litao Suna Department of Pathogens and Infectious Disease Prevention and Control, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-8415-989X View further author information

Article: 2031483 | Received 09 Nov 2021, Accepted 16 Jan 2022, Published online: 27 Feb 2022

Cite this article
https://doi.org/10.1080/19420862.2022.2031483
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Qi Zhang, Ivan Pavlinov, Yihong Ye & Wei Zheng. (2024) Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection. Frontiers in Medicine 11.
Crossref

Rahel R. Winiger & Laurent Perez. (2024) Therapeutic antibodies and alternative formats against SARS-CoV-2. Antiviral Research 223, pages 105820.
Crossref

Dalia T. Abdeldaim & Katharina Schindowski. (2023) Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. Pharmaceutics 15:10, pages 2402.
Crossref

Manolis Kogevinas, Marianna Karachaliou, Ana Espinosa, Ruth Aguilar, Gemma Castaño-Vinyals, Judith Garcia-Aymerich, Anna Carreras, Beatriz Cortés, Vanessa Pleguezuelos, Kyriaki Papantoniou, Rocío Rubio, Alfons Jiménez, Marta Vidal, Pau Serra, Daniel Parras, Pere Santamaría, Luis Izquierdo, Marta Cirach, Mark Nieuwenhuijsen, Payam Dadvand, Kurt Straif, Gemma Moncunill, Rafael de Cid, Carlota Dobaño & Cathryn Tonne. (2023) Long-Term Exposure to Air Pollution and COVID-19 Vaccine Antibody Response in a General Population Cohort (COVICAT Study, Catalonia). Environmental Health Perspectives 131:4.
Crossref

Qianran Wang, Lu Peng, Yanqiu Nie, Yanni Shu, Huajun Zhang, Zidan Song, Yufeng Li, Hengrui Hu, Liushuai Li, Xi Wang, Jia Liu, Jiang Li, Zhengli Shi, Fei Deng, Yu Guo, Yiwu Zhou, Bing Yan, Zhihong Hu & Manli Wang. (2023) Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo. Virologica Sinica 38:2, pages 257-267.
Crossref

Fabian Bohländer. (2023) A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases. Frontiers in Immunology 14.
Crossref

Siew Pheng Lim. (2023) Targeting SARS-CoV-2 and host cell receptor interactions. Antiviral Research 210, pages 105514.
Crossref

Wenbin Zhao, Xiaowei Luo, Fan Tong, Xiangwen Zheng, Jing Li, Guangyu Zhao & Dongsheng Zhao. (2023) Improving antibody optimization ability of generative adversarial network through large language model. Computational and Structural Biotechnology Journal 21, pages 5839-5850.
Crossref

Chiara Oltolini, Raffaella Greco & Maria Teresa Lupo Stanghellini. 2023. Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation. Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation 177 192 .

María Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, Javier Villarraza, Ernesto Garay, Antonela Fuselli, Victoria Gastaldi, María Belén Tardivo, Sebastián Antuña, Diego Fontana & Claudio Prieto. (2022) Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein. Applied Microbiology and Biotechnology 106:23, pages 7933-7948.
Crossref

Carlota Dobaño, Anna Ramírez-Morros, Selena Alonso, Rocío Rubio, Gemma Ruiz-Olalla, Josep Vidal-Alaball, Dídac Macià, Queralt Miró Catalina, Marta Vidal, Aina Fuster Casanovas, Esther Prados de la Torre, Diana Barrios, Alfons Jiménez, Jasmina Zanoncello, Natalia Rodrigo Melero, Carlo Carolis, Luis Izquierdo, Ruth Aguilar, Gemma Moncunill & Anna Ruiz-Comellas. (2022) Sustained seropositivity up to 20.5 months after COVID-19. BMC Medicine 20:1.
Crossref

Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jaksic, Barbora Weinbergerová, Caroline Besson, Rafael F. Duarte, Federico Itri, Toni Valković, Tomáš Szotkovski, Alessandro Busca, Anna Guidetti, Andreas Glenthøj, Graham P. Collins, Valentina Bonuomo, Uluhan Sili, Guldane Cengiz Seval, Marina Machado, Raul Cordoba, Ola Blennow, Ghaith Abu-Zeinah, Sylvain Lamure, Austin Kulasekararaj, Iker Falces-Romero, Chiara Cattaneo, Jaap Van Doesum, Klára Piukovics, Ali S. Omrani, Gabriele Magliano, Marie-Pierre Ledoux, Cristina de Ramon, Alba Cabirta, Luisa Verga, Alberto López-García, Maria Gomes Da Silva, Zlate Stojanoski, Stef Meers, Tobias Lahmer, Sonia Martín-Pérez, Julio Dávila-Vals, Jens Van Praet, Michail Samarkos, Yavuz M. Bilgin, Linda Katharina Karlsson, Josip Batinić, Anna Nordlander, Martin Schönlein, Martin Hoenigl, Zdeněk Ráčil, Miloš Mladenović, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Nick De Jonge, Tatjana Adžić-Vukičević, Raquel Nunes-Rodrigues, Lucia Prezioso, Milan Navrátil, Monia Marchetti, Annarosa Cuccaro, Maria Calbacho, Antonio Giordano, Oliver A. Cornely, José-Ángel Hernández-Rivas & Livio Pagano. (2022) B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA). Frontiers in Oncology 12.
Crossref

Malika Hale, Jason Netland, Yu Chen, Christopher D. Thouvenel, Katherine Nabel Smith, Lucille M. Rich, Elizabeth R. Vanderwall, Marcos C. Miranda, Julie Eggenberger, Linhui Hao, Michael J. Watson, Charles C. Mundorff, Lauren B. Rodda, Neil P. King, Miklos Guttman, Michael GaleJrJr, Jonathan Abraham, Jason S. Debley, Marion Pepper & David J. Rawlings. (2022) IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2. Journal of Experimental Medicine 219:9.
Crossref

Patrícia de Sousa-Pereira, Dennis K. Lanning, Pedro J. Esteves, Christian Spoerry, Jenny M. Woof & Ana Pinheiro. (2022) Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents. Frontiers in Immunology 13.
Crossref

Siqi Gong, Seijal Gautam, Joshua D. Coneglio, Hanna B. Scinto & Ruth M. Ruprecht. (2022) Antibody Light Chains: Key to Increased Monoclonal Antibody Yields in Expi293 Cells?. Antibodies 11:2, pages 37.
Crossref

William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt & Lila M. Strohl. (2022) Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. BioDrugs 36:3, pages 231-323.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

Citations (16)

Articles from other publishers (16)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date